Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Fermenta Biotech LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs
BSE Code:506414NSE Symbol: Not ListedP/E(TTM):10.85
ISIN Demat:INE225B01021Div & Yield %:0.71EPS(TTM):32.37
Book Value(Rs):136.8250387Market Cap ( Cr.):1033.47Face Value(Rs):5
    Change Company 
( In Cr)
 Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
INCOME :      
Sales Turnover 430.53307.09328.91387.96372.82300.51
Excise Duty0.000.000.000.000.001.24
Net Sales430.53307.09328.91387.96372.82299.27
Other Income 11.688.158.467.536.6212.31
Stock Adjustments 7.59-13.86-17.29-7.6515.8820.79
Total Income449.80301.38320.08387.84395.32332.37
EXPENDITURE :      
Raw Materials 146.2291.57109.21136.55139.52103.46
Power & Fuel Cost27.2319.7818.2420.3514.2312.74
Employee Cost 60.1053.9353.8159.3657.5050.03
Other Manufacturing Expenses 57.0050.2944.1243.6536.0627.85
Selling and Administration Expenses 39.0834.4638.7338.1637.2547.28
Miscellaneous Expenses 7.7414.8768.125.429.418.25
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure337.37264.90332.23303.50293.96249.61
Operating Profit112.4336.49-12.1484.35101.3682.75
Interest 14.8417.4021.3518.1119.1020.27
Gross Profit97.5919.09-33.4966.2482.2662.48
Depreciation23.1723.7024.4923.6719.0314.94
Profit Before Tax74.42-4.61-57.9842.5763.2347.54
Tax13.1214.14-0.977.4111.263.37
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax-6.320.000.004.920.00-19.49
Reported Net Profit67.62-18.74-57.0030.2451.9763.67
Extraordinary Items -4.09-11.01-60.09-0.02-0.131.90
Adjusted Net Profit71.71-7.733.0930.2652.1061.77
Adjst. below Net Profit -0.800.129.52-0.24-0.04-6.22
P & L Balance brought forward276.80299.03350.72327.93275.99218.54
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 3.613.614.207.210.000.00
P & L Balance carried down340.00276.80299.03350.72327.93275.99
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %50.0025.0025.0025.0050.00100.00
Earnings Per Share-Unit Curr23.18-6.49-19.7510.4818.0122.07
Earnings Per Share(Adj)-Unit Curr23.18-6.49-19.7510.4818.0122.07
Book Value-Unit Curr130.26108.83116.45137.26128.42108.36